CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
1.92
2.54%
Market Trading Hours* (UTC) Opens on Monday at 08:00

Mon: 08:00 - 16:30

Tue: 08:00 - 12:55

Fri: 08:00 - 16:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.03
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.019346 %
Charges from full value of position ($-3.68)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.019346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.002876 %
Charges from full value of position ($-0.55)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.002876%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange France
Commission on trade 0%

Key Stats
Prev. Close 1.97
Open 2.09
1-Year Change -56.73%
Day's Range 1.91 - 2.09
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 20, 2024 1.92 -0.25 -11.52% 2.17 2.17 1.89
Dec 19, 2024 1.97 0.16 8.84% 1.81 2.00 1.78
Dec 18, 2024 1.81 0.07 4.02% 1.74 1.83 1.72
Dec 17, 2024 1.76 0.05 2.92% 1.71 1.79 1.70
Dec 16, 2024 1.75 0.00 0.00% 1.75 1.80 1.71
Dec 13, 2024 1.81 0.02 1.12% 1.79 1.84 1.79
Dec 12, 2024 1.83 -0.01 -0.54% 1.84 1.87 1.81
Dec 11, 2024 1.85 -0.03 -1.60% 1.88 1.92 1.84
Dec 10, 2024 1.93 0.02 1.05% 1.91 2.00 1.90
Dec 9, 2024 1.96 0.00 0.00% 1.96 2.00 1.92
Dec 6, 2024 1.91 0.12 6.70% 1.79 1.92 1.79
Dec 5, 2024 1.83 -0.08 -4.19% 1.91 1.96 1.82
Dec 4, 2024 1.92 0.09 4.92% 1.83 2.00 1.81
Dec 3, 2024 1.82 0.04 2.25% 1.78 1.90 1.78
Dec 2, 2024 1.77 0.00 0.00% 1.77 1.84 1.77
Nov 29, 2024 1.82 0.01 0.55% 1.81 1.88 1.79
Nov 28, 2024 1.85 0.03 1.65% 1.82 1.91 1.82
Nov 27, 2024 1.83 -0.08 -4.19% 1.91 1.95 1.81
Nov 26, 2024 1.88 -0.12 -6.00% 2.00 2.00 1.85
Nov 25, 2024 1.99 -0.05 -2.45% 2.04 2.09 1.98

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Valneva SE Company profile

About Valneva SE

Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Financial summary

BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.

Equity composition

07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).

Industry: Biotechnology & Medical Research (NEC)

6 rue Alain Bombard
SAINT-HERBLAIN
PAYS DE LA LOIRE 44800
FR

People also watch

US100

21,269.40 Price
+0.710% 1D Chg, %
Long position overnight fee -0.0234%
Short position overnight fee 0.0012%
Overnight fee time 22:00 (UTC)
Spread 7.0

ETH/USD

3,294.95 Price
-0.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,623.59 Price
+1.110% 1D Chg, %
Long position overnight fee -0.0151%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

2.23 Price
-0.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01112

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading